Report overview
This report aims to provide a comprehensive presentation of the global market for Biosimilar Testing and Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Testing and Development Services. This report contains market size and forecasts of Biosimilar Testing and Development Services in global, including the following market information:
Global Biosimilar Testing and Development Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biosimilar Testing and Development Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.
We surveyed the Biosimilar Testing and Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Testing and Development Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, by Type, 2022 (%)
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Global Biosimilar Testing and Development Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, by Application, 2022 (%)
PK assay
Tiered Immunogenicity testing
NAb assays
Global Biosimilar Testing and Development Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilar Testing and Development Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biosimilar Testing and Development Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biosimilar Testing and Development Services, market overview.
Chapter 2: Global Biosimilar Testing and Development Services market size in revenue.
Chapter 3: Detailed analysis of Biosimilar Testing and Development Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilar Testing and Development Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
